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The IAN (immune-associated nucleotide-binding protein) family is a family of functionally uncharacterized GTP-binding
proteins expressed in vertebrate immune cells and in plant cells during antibacterial responses. Here we show that all
eight IAN family genes encoded in a single cluster of mouse genome are predominantly expressed in lymphocytes, and
that the expression of IAN1, IAN4, and IAN5 is significantly elevated upon thymic selection of T lymphocytes. Gain-of-
function experiments show that the premature overexpression of IAN1 kills immature thymocytes, whereas short
hairpin RNA-mediated loss-of-function studies show that IAN4 supports positive selection. The knockdown of IAN5
perturbs the optimal generation of CD4/CD8 double-positive thymocytes and reduces the survival of mature T
lymphocytes. We also show evidence suggesting that IAN4 and IAN5 are associated with anti-apoptotic proteins Bcl-2
and Bcl-xL, whereas IAN1 is associated with pro-apoptotic Bax. Thus, the IAN family is a novel family of T cell–receptor-
responsive proteins that critically regulate thymic development and survival of T lymphocytes and that potentially
exert regulatory functions through the association with Bcl-2 family proteins.
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Introduction
The development of T lymphocytes in the thymus involves
a series of checkpoints, including T cell receptor (TCR)–
mediated positive and negative selection. Positive selection
ensures the selective survival of potentially useful T cells,
whereas negative selection deletes harmful T cells, avoiding
autoimmunity. Differential ligand–TCR interactions that
result in positive and negative selection initiate differential
intracellular signals that, in turn, lead to the survival-or-death
decision of immature thymocytes [1–3]. The Bcl-2 family
proteins are known to play crucial roles in regulating the
survival and apoptosis of developing thymocytes. Anti-
apoptotic Bcl-2 family members, such as Bcl-2, Bcl-xL, and
Mcl-1, support the survival and development of T lympho-
cytes [4–6], whereas pro-apoptotic members, such as Bax, Bak,
and Bim, essentially mediate the deletion of self-reactive
thymocytes [7,8]. However, how the TCR signals result in the
regulation of thymocyte fate by the Bcl-2 family members is
unclear.
To better understand the molecular mechanisms that
regulate T-lymphocyte development and selection, an oligo-
nucleotide microarray was screened for mouse cDNA that
was highly expressed in positive-selector TCR-transgenic
thymocytes. We found that IAN1 and IAN4 are expressed
upon the positive selection of thymocytes. IAN1 and IAN4
belong to the recently discovered IAN (immune-associated
nucleotide-binding protein)/GIMAP (GTPase of the immun-
ity-associated protein) family of genes that encode function-
ally unknown GTP-binding proteins expressed in immune
tissues [9–29]. It has been shown that IAN1 expression is
predominant in the lymphoid cells, increased upon thymo-
cyte maturation [9,10], and decreased in human T-leukemia
cells [11], whereas the expression of mouse IAN2/imap38 is
elevated in the spleens of mice infected with the experimental
malarial parasite Plasmodium chabaudi [12–14]. It has been also
shown that IAN4 and IAN5 are highly expressed in leukemia
cells in mouse and human, respectively [15,22], whereas
human IAN5 inhibits the apoptosis induced by okadaic acid
[21]. However, the function of the IAN family genes in
lymphocyte development has been poorly characterized.
Thus far, the most conclusive results on the role of the IAN
family members come from studies of the BB rat, an animal
model for type I diabetes [16–20,25–27]. The BB rat
spontaneously develops insulin-dependent diabetes and ex-
hibits lifelong T lymphopenia in which the numbers of
peripheral CD4
þ and CD8
þ T cells are severely reduced
[30,31]. Recent studies have identiﬁed a frame-shift mutation
in IAN5, which is responsible for the T lymphopenia in the BB
rat [16–20]. It has been further reported that IAN5 is involved
in the regulation of T cell activation [25] and in the post-
thymic development of CD4
þ CD25
þ regulatory T cells [26].
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PLoS BIOLOGYThese ﬁndings suggest that IAN5 plays an important role in
the maintenance and regulation of peripheral T lymphocytes.
The present study shows that the mouse genome encodes
eight functional IAN genes within a tight cluster, and that
among the eight IAN family members, IAN1, IAN4, and IAN5
are highly expressed in T lymphocytes, and their expression is
signiﬁcantly elevated in immature thymocytes upon TCR-
mediated positive selection. Retroviral overexpression and
short hairpin RNA (shRNA)–mediated knockdown in devel-
oping thymocytes indicate that IAN1, IAN4, and IAN5 critically
and differentially inﬂuence the survival and development of T
lymphocytes. The knockdown of IAN4 and IAN5 disturbs
thymocyte development at different stages, whereas the
premature overexpression of IAN1 induces the apoptosis of
immature thymocytes. It is further suggested that IAN4 and
IAN5 are associated with anti-apoptotic proteins Bcl-2 and
Bcl-xL, whereas IAN1 is associated with pro-apoptotic Bax.
Importantly, Bcl-xL was found to interfere with the IAN5-
mediated regulation of T cell survival. Taken together, these
results indicate that the IAN family genes encode a novel
family of TCR-responsive proteins that critically regulate the
survival and death of developing T lymphocytes and that
potentially do so via the association with Bcl-2 family proteins.
Results
Mouse IAN Gene Cluster Encodes Eight Proteins with GTP-
Binding Motifs
Using oligonucleotide microarray analysis, we screened for
mouse cDNA that was highly expressed in positive-selector H-
2
b AND-TCR–transgenic thymocytes [32]. In addition to
previously characterized genes such as CCR7, we found that
IAN1 and IAN4 were expressed at higher levels in the positive-
selector thymocytes than in the wild-type thymocytes (Table
S1). In the mouse genome, eleven IAN genes were previously
predicted to lie within a tight cluster on Chromosome 6 [17].
By analyzing the nucleotide sequences of BAC clones and
PCR-ampliﬁed C57BL/6 genomic DNA, we identiﬁed mouse
IAN1, IAN2, IAN3, IAN4, IAN5, IAN6, and IAN7 (Figure 1A),
which were transcribed in immune tissues (Figure S1A).
Provisional IAN8 was identiﬁed to be a pseudogene, because
it had stop codons and multiple frame shifts in possible
coding frames, and its transcript was undetected (Figure S1B).
Provisional IAN9, IAN10, and IAN11 were transcribed and
spliced into a single mRNA encoding a protein with three
GTP-binding motifs (Figure 1B, Figure S2), and thus renamed
IAN9, in agreement with the recently described human gimap8
[28] and rat IAN9 [29].
Figure 1B shows the predicted structures of all the eight
members of the IAN family proteins in mice. The AIG1
domain [22] that contains a GTP-binding motif and a
functionally undeﬁned RxxxhNN[R,K][A,E] (h, hydrophobic
amino acids) sequence, designated as the IAN motif, was
found in all the members. All members except IAN2 carried
the coiled-coil motif. IAN4 and IAN5 showed markedly high
similarity in amino acids (83.8% identity in 291 aa) and in
ORF nucleotides (88.9% identity in 873 bp) (Figure S3).
In addition to mouse, every vertebrate examined so far
contained the IAN family gene cluster (Figure 1A and 1C),
whereas no IAN genes were found in the genomes of
invertebrates and microorganisms that were registered in
Figure 1. IAN Family Genes
(A) The cluster of IAN family genes in the genome of indicated species. Mouse IAN genes and their orthologs in human and rat are indicated. For
chicken, zebrafish, and thale cress, arrows indicate genes that putatively encode AIG1-domain-containing proteins. In chicken, 19 genes are predicted to
encode AIG1 domain–containing proteins, and arrows indicate 15 genes clustered on Chromosome 2. In zebrafish, a cluster of 23 genes was found on
Chromosome 16. In thale cress, ten out of 14 predicted genes are clustered on Chromosome 1.
(B) Predicted structures of mouse IAN family proteins. Numbers refer to amino acid residues of full-length proteins.
(C) A neighbor-joining tree of the AIG1 domain of IAN proteins. A. thaliana AIG1, residues 44–243; N. tabacum NTGP4 (AAD09518), residues 23–222; G.
max NTGP4 (BI316235), residues 1–118; O. sativa AIG1 (CAE04223), residues 31–230; Z. mays AIG1 (AW120061), residues 1–200; D. rerio IAN (BC053197),
residues 1–200; G. gallus IAN (XP_427942), residues 3–202; M. musculus IAN1, residues 31–230; R. norvegicus IAN1, residues 31–230; H. sapiens IAN1,
residues 45–244. No IAN genes were found in the genomes of Drosophila melanogaster (fly), Anopheles gambiae (mosquito), Ciona intestinalis (sea
squirt), Caenorhabditis elegans (nematode), Saccharomyces cerevisiae (yeast), and all bacteria and archea.
DOI: 10.1371/journal.pbio.0040103.g001
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IAN Family in T Lymphocyte Developmentthe public databases of NCBI and Ensembl, suggesting that
the IAN family genes may play a role in the adaptive immune
system in vertebrates. Interestingly, a cluster of the IAN
family genes was found in the genome of Arabidopsis thaliana
(Figure 1A), and this cluster included AIG1, the expression of
which was elevated upon infection by pathogenic bacteria
[33]. Other higher plants also carried the IAN family genes
(Figure 1C).
IAN1, IAN4, and IAN5 Expression Is Increased upon Positive
Selection of Thymocytes
Quantitative real-time PCR (polymerase chain reaction)
revealed that all eight members of the IAN family in mouse
were expressed abundantly in the spleen and the lymph node,
followed by the thymus, bone marrow, and lung, but were
poorly expressed in other tissues (Figure 2A). In the spleen, all
the IAN genes were predominantly expressed in CD4
þ, CD8
þ,
or B220
þlymphocytes rather than in Mac1
þmyeloid cells, and
the expression of IAN1, IAN4, IAN5, and IAN7 was higher in T
lymphocytes than in B lymphocytes (Figure 2A). In the thymus,
the expression of IAN1 and IAN4 was robustly elevated during
the development of CD4/CD8 double-positive (DP) thymo-
cytes into CD4 single-positive (SP) and CD8SP thymocytes
(Figure 2A), in agreement with the initial microarray results
(Table S1). Among the other IAN family members, the
expression of IAN3 and IAN5 was moderately but signiﬁcantly
Figure 2. Expression of Mouse IAN Family Genes
(A) Quantitative RT-PCR analysis of total RNA from C57BL/6 mouse tissues, purified splenocyte subsets, and purified thymocyte subsets. The mRNA
levels of IAN family genes were initially normalized to GAPDH levels, and were further normalized to the levels expressed in the thymus. Relative
expression of all IAN family genes in the thymus tissue is indicated as 1.
(B) Relative mRNA levels of IAN1, IAN4, and IAN5 in CD4
þCD8
þ, CD4
þCD8
þCD5
low, and CD4
þCD8
þCD5
high thymocytes from C57BL/6 (wild-type) mice and
CD4
þCD8
þ thymocytes from TCRa-deficient mice [42].
(C) IAN1, IAN4, and IAN5 mRNA levels in CD4
þCD8
þthymocytes from positive selector (AND-TCR Ab
þ/þand 2C-TCR
k/b [43]) TCR-transgenic mice and null
selector (AND-TCR Ab
 /  [44] and 2C-TCR
k/k) TCR-transgenic mice.
(D) Relative mRNA levels of IAN1, IAN4, and IAN5 in total, CD4
þCD8
þCD69
low, CD4
þCD8
þCD69
high, CD4
þCD8
 CD69
high and CD4
þCD8
 CD69
low
thymocytes from C57BL/6 mice.
(E) Thymocytes from TCRa-deficient mice were cultured with or without phorbol 12-myristate 13-acetate (0.2 ng/ml) and ionomycin (0.2 lg/ml) for the
indicated periods.
(F) Thymocytes from Ab
 / b2m
 / mice [45] were cultured with or without plate-bound anti-CD3e (clone 2C11) and anti-CD28 (clone 37.51) antibodies
for 24 h.
Bar graphs show means 6 standard errors.
DOI: 10.1371/journal.pbio.0040103.g002
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IAN Family in T Lymphocyte Developmentincreased during the development of DP cells into SP cells
(Figure 2A). Thus, IAN1, IAN4, and IAN5 are highly expressed
in T lymphocytes, and their expression is signiﬁcantly elevated
upon the maturation of DP to SP thymocytes.
The expression of IAN1, IAN4, and IAN5 was higher in DP
CD5
high thymocytes than in DP CD5
low thymocytes or TCRa-
deﬁcient DP thymocytes (Figure 2B), and higher in positive-
selector DP thymocytes than in null-selector DP thymocytes
in TCR-transgenic mice (Figure 2C). In normal mouse
thymocyte subpopulations, the expression of IAN1, IAN4,
and IAN5 was increased in accordance with the positive
selection of immature DP thymocytes to mature SP thymo-
cytes, including the increase along the early events during the
development of DP CD69
low cells to DP CD69
high cells and the
increase along the late events during the development of
CD4SP CD69
high cells to CD4SP CD69
low cells (Figure 2D). In
vitro stimulation of TCRa-deﬁcient DP thymocytes with
phorbol 12-myristate 13-acetate and ionomycin resulted in
marked increases in IAN1 and IAN4 expression and a modest
increase in IAN5 expression (Figure 2E). Similarly, in vitro
stimulation of immature DP thymocytes, which were isolated
from MHC class I and class II double-deﬁcient mice, with
anti-CD3e and anti-CD28 antibodies signiﬁcantly increased
IAN1, IAN4, and IAN5 expression (Figure 2F). Thus, the
expression of IAN1, IAN4, and IAN5 is increased during the
positive selection of thymocytes.
Premature Overexpression of IAN1 Causes Apoptosis of
DP Thymocytes
To study the roles of IAN1, IAN4, and IAN5 in thymocyte
development, CD4/CD8 double-negative (DN) immature
thymocytes obtained from day 14.5 fetal mice were infected
with retroviruses that overexpressed IAN genes along with
enhanced green ﬂuorescent protein (EGFP) (Figure 3A–3C)
Figure 3. Overexpression of IAN1, IAN4, and IAN5 in Thymocyte Development
(A) Diagram of MSCV retroviral constructs.
IRES, internal ribosomal entry site; LTR, long terminal repeat; W, packaging signal.
(B) NIH-3T3 cells infected with retroviruses expressing IAN1-HA, IAN4, IAN5, or EGFP alone were analyzed for EGFP fluorescence by flow cytometry and
for IAN protein expression by immunoblotting (IB). The frequency of cells and the mean fluorescence intensity (MFI) in the indicated area are shown.
(C) Day 14.5 fetal thymocytes infected with indicated retroviruses were reconstituted in FTOC. EGFP
þ cells purified on day 6 were analyzed for mRNA
expression.
(D) Viable cell numbers of total cells (striped bars) and EGFP
þ cells (open bars) in FTOC on day 6. Filled bar indicates a significant reduction (p , 0.01).
EGFP, n ¼ 7; IAN1, n ¼ 6; IAN4, n ¼ 6; IAN5, n ¼ 6.
(E) EGFP histograms of total cells and CD4/CD8 profiles of EGFP
þcells in FTOC on day 6. Numbers in dot plots show the frequency of cells within boxes.
(F) Annexin V and PI staining of indicated EGFP
þ thymocyte subpopulations in FTOC on day 6. Filled bar indicates a significant increase (p , 0.05).
Bar graphs show means 6 standard errors.
NS, not significant (p   0.05); *p , 0.05; **p ,0.01. No significant difference in the CD4/CD8 developmental profiles was observed in EGFP
  cell
populations.
DOI: 10.1371/journal.pbio.0040103.g003
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IAN Family in T Lymphocyte Developmentand examined for developmental capability in 2-deoxygua-
nosine-treated fetal thymus. It was found that the over-
expression of IAN1 reduced the number of EGFP
þthymocytes
(Figure 3D) and the EGFP intensity of those EGFP
þ
thymocytes (Figure 3E). The increase in frequency of DN
thymocytes and the decrease in frequency of DP thymocytes
were modestly but signiﬁcantly caused in the EGFP
þ cells by
the IAN1 overexpression (Figure 3E). The frequency of
apoptotic cells was signiﬁcantly increased in IAN1 over-
expressing EGFP
þ DP thymocytes but not in EGFP
þ DN
thymocytes (Figure 3F). These effects of IAN1 overexpression
were detected only in EGFP
þ cells and not in coexisting
EGFP
  cells (Figure 3D) that failed to express retrovirus-
mediated genes and that comprised more than 30% of total
thymocytes in the fetal thymus organ culture (FTOC) (Figure
3E), indicating that the effects of IAN1 overexpression were
speciﬁc for the IAN1-overexpressing cells but not for co-
existing EGFP
 thymocytes, and that the IAN1 overexpression
affected thymocyte development in the presence of normally
developing thymocytes. Thus, the premature overexpression
of IAN1 kills DP thymocytes, disturbing subsequent T cell
development. By contrast, the overexpression of IAN4 or
IAN5 did not signiﬁcantly inﬂuence thymocyte development
(Figure 3D and 3E).
Knockdown of IAN4 and IAN5 Differentially Disturbs
Thymocyte Development
Loss-of-function examination of thymocyte development
was carried out using the retrovirus-mediated RNA interfer-
ence technique. In this technique, shRNA was expressed
under the control of the PolIII-dependent U6 promoter
(Figure 4A). The shRNA markedly and speciﬁcally decreased
the expression of IAN1, IAN4, and IAN5 in immature T cells at
both mRNA and protein levels (Figure 4B and 4C). By
contrast, the other IAN family members, IAN2, IAN3, IAN6,
IAN7, and IAN9, were not affected by any of the shRNAs
(Figure S4), further indicating the speciﬁcity of the shRNA-
mediated knockdown.
DN immature thymocytes were infected with retroviruses
that expressed these shRNA along with EGFP, and were
transferred into 2-deoxyguanosine-treated fetal thymus. The
infection with the shRNA retroviruses did not affect cell
culture conditions or the development of uninfected cells, as
no signiﬁcant effects were detected on the number of
developing thymocytes in the EGFP
þ fractions as well as in
the EGFP
  fractions (Figure 4D) or on the developmental
proﬁles of EGFP
  thymocytes (unpublished data). It was
found that IAN1 shRNA had no signiﬁcant effects on the CD4/
CD8 proﬁle of EGFP
þ cells, whereas IAN4 shRNA caused a
signiﬁcant decrease in the generation of EGFP
þ CD4SP
thymocytes, which paralleled the increase in frequency of
EGFP
þ DP cells (Figure 4E and 4F). In agreement with the
thymocyte frequency, the cellularity of the EGFP
þ CD4SP
subpopulation was signiﬁcantly reduced by the IAN4 shRNA
expression (2.4 3 10
3 6 0.3 3 10
3 by the control luciferase
shRNA expression, and 1.0 3 10
3 6 0.2 3 10
3 by the IAN4
shRNA expression; p , 0.001). By contrast, the cell number of
the EGFP
þDP subpopulation was not signiﬁcantly affected by
the IAN4 shRNA expression (9.4 3 10
3 6 1.3 3 10
3 by the
control luciferase shRNA expression, and 8.3310
3 6 1.3310
3
by the IAN4 shRNA expression; not signiﬁcant). Furthermore,
IAN4 shRNA signiﬁcantly reduced the generation of CD8SP
CD5
high and CD4SP CD5
high mature T cells but not that of DP
thymocytes within the EGFP
þ population (Figure 5A). The
introduction of IAN4 shRNA signiﬁcantly decreased the
generation of AND-TCR–transgenic CD4SP T cells and 2C-
TCR–transgenic CD8SP CD5
high T cells (Figure 5B). Thus,
IAN4 is required for supporting the positive selection of CD4
T cells and CD8 T cells.
On the other hand, the introduction of IAN5 shRNA most
markedly decreased the frequency of DP and CD4SP cells and
increased that of DN and CD8SP immature cells within the
EGFP
þ population (Figure 4E and 4F). In agreement with the
frequency, the cellularity of EGFP
þ DP and EGFP
þ CD4SP
subpopulations was signiﬁcantly reduced by the IAN5 shRNA
expression (EGFP
þ DP cells: 9.4 3 10
3 6 1.3 3 10
3 by the
control luciferase shRNA expression, and 6.0310
3 6 0.9310
3
by the IAN5 shRNA expression (p , 0.05); EGFP
þCD4SP cells:
2.4 3 10
3 6 0.3 3 10
3 by the control luciferase shRNA
expression, and 0.9 3 10
3 6 0.2 3 10
3 by the IAN5 shRNA
expression (p , 0.001)). By contrast, the cell number of EGFP
þ
DN and EGFP
þ CD8SP immature subpopulations was
elevated by the IAN5 shRNA expression (8.6 3 10
3 6 1.0 3
10
3 by the control luciferase shRNA expression, and 12.4310
3
6 1.4 3 10
3 by the IAN5 shRNA expression; p , 0.05). The
distribution of DN subpopulations deﬁned by CD25 and
CD44 in the EGFP
þ cells was not affected by the infection of
day 14.5 fetal thymocytes that were mostly DN1 and DN2
before the culture, with the IAN5 shRNA retrovirus (Figure
5C), whereas the infection of puriﬁed DN4 thymocytes with
the IAN5 shRNA retrovirus signiﬁcantly reduced the gen-
eration of EGFP
þ DP cells but signiﬁcantly increased the
numbers of EGFP
þ DN and EGFP
þ CD8SP immature cells in
2-d FTOC (Figure 5D). These results indicate that IAN5 is
required for the optimal generation of DP thymocytes.
Association of IAN1, IAN4, and IAN5 with Bcl-2 Family
Proteins
To gain an insight into the mechanisms underlying the
regulation of thymocyte development by the IAN family
members, an antibody array of signal transduction molecules
was screened for proteins that could bind to IAN4, revealing
the selective binding of the Bcl-2 family proteins, including
anti-apoptotic Bcl-2 and Bcl-xL (Figure S5). Subsequent
examination with co-immunoprecipitation (IP) analysis using
transfected 293T cells conﬁrmed that either IAN4 or IAN5
interacted with Bcl-2 and Bcl-xL (Figure 6A). In addition,
IAN4 or IAN5 also interacted with the pro-apoptotic Bcl-2
family members Bax, Bak, Bad, and BimEL in the transfected
293T cells. By contrast, IAN1 was selectively associated with
the pro-apoptotic member, Bax, and not with the other Bcl-2
family members tested (Figure 6A). Two other unrelated
proteins, IjBa and EGFP, did not interact with any of the IAN
family proteins (Figure 6A), highlighting the speciﬁcity of the
interaction between the IAN family proteins and the Bcl-2
family proteins.
Within the BW5147 thymocyte lines that were transduced
with the IAN family genes, IAN4 and IAN5 were predom-
inantly localized in the intracellular membrane fractions,
including the mitochondria and the endoplasmic reticulum
(Figure S6), in agreement with the localization of Bcl-2 and
Bcl-xL ([34]; also shown in Figure S6B). On the other hand,
IAN1 was found in the cytoplasmic fraction (Figure S6), in
agreement with the localization of Bax [34].
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IAN Family in T Lymphocyte DevelopmentFigure 4. Knockdown of IAN1, IAN4, and IAN5 in Thymocyte Development
(A) Diagram of retroviral shRNA constructs.
Puro
r, puromycin resistance gene.
SIN-LTR, self-inactivating long terminal repeat.
(B) BW5147 cells expressing IAN1-HA, IAN4-HA, or IAN5-HA were infected with shRNA retroviruses, and the infected cells were enriched by puromycin
selection. Protein expression levels were analyzed by anti-HA IB. Luciferase (Luc) shRNA was used as control.
(C) Day 14.5 fetal thymocytes infected with shRNA retroviruses were reconstituted in FTOC. EGFP
þ cells purified on day 6 were analyzed for mRNA
expression.
(D) Viable cell numbers of total cells (striped bars) and EGFP
þ cells (open bars) in FTOC on day 6.
(E) EGFP histograms of total cells and CD4/CD8 profiles of EGFP
þ cells in FTOC on day 6. The frequency of EGFP
þ cells and the mean fluorescence
intensity (MFI) in the indicated area are shown in the histograms. Numbers in dot plots show the frequency of EGFP
þ cells within boxes.
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IAN Family in T Lymphocyte DevelopmentTo study the interaction of the IAN family proteins with
the endogenous Bcl-2 family proteins in T-lymphoid cells, we
initially tested 23–1–8 T lymphocyte clones expressing FLAG-
tagged IAN4 or FLAG-tagged IAN5. IP of FLAG-tagged IAN4
or IAN5 with anti-FLAG antibody resulted in the co-
precipitation of endogenous Bcl-2 or Bcl-xL (Figure 6B).
Reciprocally, endogenous Bcl-2 or Bcl-xL IP with anti-Bcl-2
or anti-Bcl-xL antibodies was co-precipitated with FLAG-
tagged IAN4 or IAN5 (Figure 6C). The pro-apoptotic member
Bax was also co-precipitated with FLAG-tagged IAN4 or IAN5
in 23–1–8 T cells (Figure 6D). This co-precipitation of Bax was
more pronounced in the cells that initiated apoptosis upon
IL-2 withdrawal, than in the cells exposed to IL-2 (Figure 6D),
in agreement with the apoptosis-associated translocation of
Bax from the cytoplasm to the intracellular membrane
fractions [34,35] where IAN4 and IAN5 are predominantly
localized (Figure S6).
We then analyzed the interaction between the endogenous
IAN family proteins and the endogenous Bcl-2 family
proteins in 23–1–8 T lymphocytes. As shown in Figure 6E,
IP of endogenous IAN4 with anti-IAN4 antibody led to the
co-precipitation of a small fraction of endogenously ex-
pressed Bcl-2 in the intracellular membrane fractions such as
the nuclear and heavy membrane fractions. These results
indicate that the IAN family proteins are associated with the
endogenous Bcl-2 family proteins in T lymphocytes.
IAN5 Regulates T Cell Survival and Apoptosis
Based on the ﬁndings that both IAN4 and IAN5 are
involved in the generation of T lymphocytes (Figures 4 and 5)
and are associated with the Bcl-2 family proteins (Figure 6),
we ﬁnally studied the role of these molecules in the survival
and apoptosis of T lymphocytes. We found that the knock-
down of IAN5 in the IL-2-dependent 23–1–8 T cell line
reduced the viability of the cells upon IL-2 withdrawal (Figure
7A), whereas the IAN4 knockdown had no effect in this
condition (unpublished data). Apoptosis as determined by
Annexin V staining or the loss of mitochondrial membrane
potential was also enhanced by the IAN5 shRNA (Figure 7B
and 7C). These results indicate that IAN5 is required for
(F) Frequencies of indicated cell populations on day 6.
Filled bars indicate significant difference from the values in the control group (Luc shRNA) (p , 0.05).
Bar graphs show means 6 standard errors.
NS, not significant (p   0.05);
*p , 0.05;
**p , 0.01. In (D) and (F), Luc shRNA, n ¼ 11; IAN1 shRNA, n ¼ 5; IAN4 shRNA, n ¼ 11; IAN5 shRNA, n ¼ 8. No
significant difference in the CD4/CD8 developmental profiles was observed in EGFP
  cell populations.
DOI: 10.1371/journal.pbio.0040103.g004
Figure 5. Differential Roles of IAN4 and IAN5 in Thymocyte Development
(A) Day 14.5 fetal thymocytes infected with shRNA retroviruses were reconstituted in FTOC. Frequencies of indicated cell populations on day 10 are
shown. Luc shRNA, n ¼ 4; IAN4 shRNA, n ¼ 5.
(B) Day 14.5 fetal thymocytes from AND-TCR-transgenic or 2C-TCR-transgenic mice were infected and reconstituted in C57BL/6 fetal thymus lobes for 6–
8 d. For 2C-TCR–transgenic thymocytes, mature CD8SP cells were analyzed by gating CD8SP CD5
high population. AND-Luc shRNA, n ¼ 11; AND-IAN4
shRNA, n ¼ 12; 2C-Luc shRNA, n ¼ 5; 2C-IAN4 shRNA, n ¼ 5.
(C) Day 14.5 fetal thymocytes infected with shRNA retroviruses were reconstituted in FTOC (as shown in Figure 4C–4F). EGFP
þthymocytes on day 6 were
analyzed for DN subpopulations by staining with anti-CD25 and anti-CD44 antibodies. Luc shRNA, n ¼ 6; IAN5 shRNA, n ¼ 8.
(D) CD4
 CD8
 CD25
 CD44
  DN4 cells were purified from day 17 fetal thymocytes by depleting the cells expressing CD4, CD8, CD25, or CD44, infected
with indicated retroviruses, and reconstituted in FTOC for 2 d; n ¼ 4.
Bar graphs show means 6 standard errors.
NS, not significant (p   0.05);
*p , 0.05;
**p , 0.01.
DOI: 10.1371/journal.pbio.0040103.g005
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IAN Family in T Lymphocyte DevelopmentFigure 6. Interaction of IAN Family Proteins with Bcl-2 Family Proteins
(A) 293T cells were co-transfected with FLAG-tagged IAN molecules together with Bcl-2, Bcl-xL, HA-tagged Bax, HA-tagged Bak, HA-tagged Bad, BimEL,
HA-tagged IjBa, or EGFP. Cell lysates were IP with anti-FLAG M2 antibody and IB with indicated antibodies.
(B) 23–1–8 T cells expressing EGFP alone (Vector), FLAG-tagged IAN4, or FLAG-tagged IAN5 were IP with anti-FLAG M2 antibody and IB with anti-Bcl-2 or
anti-Bcl-xL antibody.
(C) 23–1–8 T cells expressing FLAG-tagged IAN4 or FLAG-tagged IAN5 were IP with normal IgG or anti-Bcl-2 or anti-Bcl-xL antibody and IB with anti-
FLAG M2 antibody. Arrows indicate FLAG-tagged IAN4 or FLAG-tagged IAN5.
(D) 23–1–8 T cells expressing EGFP alone (Vector), FLAG-tagged IAN4, or FLAG-tagged IAN5 were cultured in the presence or absence of IL-2 for 36 h.
Cell lysates were IP with anti-FLAG M2 antibody and IB with anti-Bax antibody.
(E) Nuclear and heavy membrane fractions prepared from 23–1–8 T cells were lysed in buffer containing 1% CHAPS. The lysates were IP with normal
rabbit IgG or anti-IAN4 antibody and IB with anti-Bcl-2 antibody. Means and standard errors (n¼4) of relative intensities of the bands were analyzed by
using NIH Image software.
*p , 0.05;
**p , 0.01.
DOI: 10.1371/journal.pbio.0040103.g006
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IAN Family in T Lymphocyte Developmentsupporting the survival of T lymphocytes upon cytokine
withdrawal.
The reduced survival of the IL-2–withdrawn 23–1–8 T cells
by IAN5 shRNA was markedly restored by the additional
expression of Bcl-xL (Figure 7D). The overexpression of Bcl-xL
failed to inhibit the apoptosis of 23–1–8 T cells induced by
helenalin (Figure 7D), an inducer of caspase-dependent
apoptosis that occurs independent of Bcl-2-family–mediated
mitochondrial signals [36], indicating that the Bcl-xL–
mediated restoration of cell survival is speciﬁc for mitochon-
drial apoptosis [34]. These results indicate that the Bcl-xL
overexpression speciﬁcally interferes with the enhanced
apoptosis by IAN5 knockdown, suggesting the role of Bcl-2
family proteins in the IAN5-mediated regulation of T cell
survival.
Discussion
The present study shows that IAN1, IAN4, and IAN5 are
highly expressed in mature T lymphocytes and their
expression is signiﬁcantly elevated in DP thymocytes upon
TCR-mediated positive selection. The shRNA-mediated
knockdown of IAN4 disturbed T cell development at the
process of positive selection, whereas the knockdown of IAN5
affected the earlier stage of T cell development at the
generation of DP thymocytes. By contrast, the knockdown of
IAN1 did not signiﬁcantly affect T cell development. On the
other hand, the premature overexpression of IAN1 induced
the apoptosis of DP thymocytes, whereas the overexpression
of IAN4 or IAN5 showed no signiﬁcant effects on T cell
development. These results indicate that IAN1, IAN4, and
IAN5 critically and differentially regulate the development of
T lymphocytes in the thymus.
Our results suggest that IAN4 and IAN5 are associated with
the Bcl-2 family proteins including anti-apoptotic Bcl-2 and
Bcl-xL as well as pro-apoptotic Bax, whereas IAN1 is
selectively associated with Bax. The overexpression of Bcl-
xL restored the reduced survival of T cells caused by IAN5
deﬁciency, suggesting the role of Bcl-xL in the IAN5-
mediated regulation of T cell survival. Our results also show
that TCR signals in immature thymocytes upregulate the
expression of IAN1, IAN4, and IAN5. Although it is possible
that the expression and function of these IAN family
members in developing thymocytes may also be regulated
by the survival signals derived from other receptors, such as
the IL-7 receptor and Notch-1, our results suggest that IAN1,
IAN4, and IAN5 may relay TCR signals for apoptosis
regulation by the Bcl-2 family members, critically controlling
the survival and death of immature thymocytes and possibly
regulating the repertoire selection of developing T cells in
the thymus.
IAN4 and IAN5 are highly similar in terms of primary
structure and subcellular localization. However, the knock-
down of IAN4 and IAN5 differentially affected thymocyte
development; i.e., IAN4 deﬁciency disturbed positive-selec-
tion–mediated SP thymocyte generation, whereas IAN5
deﬁciency affected DP thymocyte generation (Figures 4 and
5). As the expression of IAN5 but not IAN4 was detected in the
newly generated DP thymocytes before the TCR engagement
(e.g., TCRa-deﬁcient DP thymocytes in Figure 2B, and DP
CD69
low thymocytes in Figure 2D), the differential effects of
IAN4 deﬁciency and IAN5 deﬁciency may be due, at least in
part, to their differential expression proﬁles in the develop-
ing thymocytes. On the other hand, it was also shown that the
knockdown of IAN5, but not IAN4, enhanced the apoptosis of
the IL-2–dependent T cell line upon IL-2 withdrawal,
suggesting that IAN4 and IAN5 differentially regulate the
survival of mature T cells that express both IAN4 and IAN5.
The differential functions of IAN4 and IAN5 may also be
applied to developing thymocytes. We are currently produc-
ing mice deﬁcient in either IAN4 or IAN5 in order to
Figure 7. Knockdown of IAN5 in 23–1–8 T Lymphocytes
(A) 23–1–8 T lymphocyte clones expressing shRNAs were analyzed for
IAN5 mRNA expression and cultured in the presence or absence of IL-2.
Cell viability was quantified by PI staining and flow cytometry analysis.
(B and C) Cells in 48-h culture were analyzed for apoptosis induction.
Frequencies of Annexin-V-positive cells (B) or mitochondrial membrane
potential (Dwm)-negative cells (C) are shown.
(D) 23–1–8 T cells expressing shRNAs with or without human Bcl-xL were
analyzed for IAN5 expression by quantitative RT-PCR and for human Bcl-
xL expression by conventional RT-PCR (left panel). Cells were cultured in
the presence or absence of IL-2 for 72 h or in the presence of IL-2 and 5
lM helenalin for 48 h, and cell viability was quantified by PI staining
(right panel).
Graphs show means 6 standard errors.
NS, not significant (p   0.05);
**p , 0.01.
DOI: 10.1371/journal.pbio.0040103.g007
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thymocyte development and selection as well as mature T
cell survival in vivo.
It was previously reported that IAN4 and IAN5 are highly
expressed in leukemia cells [15,22]. However, our results
showed that the overexpression of either IAN4 or IAN5 did
not signiﬁcantly inﬂuence the cellularity or development of
immature thymocytes in FTOC (Figure 3). It is thus possible
that in promoting cellular growth and/or oncogenesis, IAN4
and IAN5 may differentially affect immature thymocytes and
other lymphoid cells including mature T lymphocytes. In vivo
analysis of the long-term effects, including malignancy, of
IAN4 or IAN5 overexpression in hematopoietic cells is in
progress.
It was previously shown that a mutational loss of IAN5 in
rat (lyp mutation) causes T lymphopenia [16–20], which leads
to the development of insulin-dependent type I diabetes [30].
IAN5 deﬁciency in rat T lymphocytes causes mitochondrial
dysfunction and spontaneous apoptosis [18]. However, the
molecular mechanism underlying the regulation of T cell
survival by IAN5 was not clariﬁed. Our results indicate that
IAN5 knockdown enhances the apoptosis of T lymphocytes
upon cytokine withdrawal, and that the reduced survival of T
cells by the IAN5 knockdown is restored by the over-
expression of Bcl-xL. Our results also suggest that IAN5 is
associated with the Bcl-2 family proteins. Together, the
present results suggest that IAN5 expressed in T lymphocytes
regulates the mitochondria-mediated apoptosis pathway
through the interaction with the Bcl-2 family proteins.
Our results also show that the IAN5 knockdown perturbs
the generation of DP thymocytes. This perturbation appears
to occur during the differentiation of CD8SP immediate
precursor cells to DP thymocytes (Figure 5C and 5D). A similar
phenotype of the thymocytes was described in vivo in IAN5-
deﬁcient rat, in which the number of DP thymocytes was
reduced and that of DN thymocytes was increased [19].
Interestingly, this phenotype was found in not only lyp/lyp rats
but also lyp/þrats [19], indicating that thehaploinsufﬁciency of
IAN5affectsthymocyte development. Indeed,our resultsshow
that the reduction of IAN5 mRNA level to approximately 50%
could affect thymocyte development (Figure 4C and 4F),
supporting the notion that the amount of IAN5 expression
critically regulates the generation of DP thymocytes.
The molecular basis for the association of the IAN family
proteins with the Bcl-2 family proteins is still unclear. Our
results show that either IAN4 or IAN5 interacts with
endogenous Bax in apoptotic T cells rather than in healthy
growing T cells even though the total amount of intracellular
Bax expression is equivalent in apoptotic cells and growing
cells (Figure 6D). It was previously shown that Bax, which is
localized in the cytosol of normal cells, responds to apoptosis-
inducing stimuli by translocating onto the mitochondrial
membrane where apoptotic reactions including DWm loss
and cytochrome-c release are operated [34,35]. Thus, the
interaction between Bax and IAN4 or IAN5 is likely regulated
by the apoptotic stress-induced translocation of Bax to the
mitochondria where IAN4 and IAN5 are localized. These
results suggest that the association between the IAN family
proteins and the Bcl-2 family proteins, including the pro-
apoptotic proteins such as Bax, likely reﬂects a speciﬁc
association with physiological relevance rather than merely a
detection of nonspeciﬁc binding between overexpressed
molecules. Accordingly, we detected the association between
endogenous IAN4 and endogenous Bcl-2 in T cells. The
speciﬁc association at the mitochondria between anti-
apoptotic Bcl-xL and either IAN4 or IAN5 is further
supported by our preliminary results that the deletion of
the C-terminal hydrophobic region from either one of Bcl-
xL, IAN4, or IAN5 caused the failure in their mitochondrial
localization and in the association between Bcl-xL and either
IAN4 or IAN5 (unpublished data). We are currently studying
the structural basis for the intracellular association between
the IAN family proteins and the Bcl-2 family proteins in
detail to elucidate the molecular mechanisms of IAN-family–
mediated apoptosis regulation.
Finally, our results showed that the premature overexpres-
sion of IAN1 kills DP thymocytes. Our results also showed that
unlike IAN4 and IAN5, IAN1 is selectively associated with pro-
apoptotic Bax rather than anti-apoptotic Bcl-2 or Bcl-xL.
Thus, IAN1 may be involved in regulating the apoptosis of
immature DP thymocytes, possibly during the negative
selection of self-reactive thymocytes. However, in agreement
with previous reports [9,10], our results showed that the
expression of IAN1 is increased during the positive selection
of thymocytes. It is possible that differential TCR signals that
determine the positive and negative selection of immature
thymocytes may critically regulate the timing and amount of
IAN1 expression; high-avidity and/or strong TCR engagement
may result in a rapid and/or marked elevation of IAN1, which
may cause the apoptosis of immature thymocytes, whereas
low-avidity and/or weak TCR engagement may slowly and/or
modest increase IAN1 expression, which may not be sufﬁcient
to kill positively selected thymocytes. We are currently
studying the role of IAN1 in positive and negative selection
in greater detail by using TCR-transgenic thymocytes.
In conclusion, the present results indicate that the IAN
family genes encode a novel family of TCR-responsive
proteins that critically regulate the survival and death of
developing T lymphocytes. As the ﬁrst described gene cluster
conserved in vertebrates and higher plants, the IAN family
may also provide clues to yet unknown self-defense mecha-
nisms common in higher organisms.
Materials and Methods
Oligonucleotide microarray. Total RNA extracted from thymocytes
of H-2
b AND-TCR–transgenic mice and C57BL/6 mice was reverse-
transcribed, in vitro transcribed in the presence of biotinylated UTP
and CTP (Enzo Diagnostics, New York, New York, United States), and
hybridized to an oligonucleotide array (Murine Genome U74Av2,
U74Bv2, and U74Cv2, Affymetrix, Santa Clara, California, United
States). Fluorescence intensities were captured with a laser confocal
scanner (Hewlett-Packard, Palo Alto, California, United States), and
analyzed with Microarray Suite Version 4.0 software (Affymetrix).
Two independent experiments were performed to ascertain the
reproducibility. Array data has been deposited in the Gene
Expression Omnibus (GEO) database (accession number GSE3909).
Bioinformatic analysis. Genome sequences were obtained from
Celera database (http://www.celera.com), NCBI public database (http://
www.ncbi.nih.gov), Ensembl database (http://www.ensembl.org/index.
html), and InterPro database (http://www.ebi.ac.uk/interpro). AIG1
domain and coiled-coil motifs were identiﬁed using CD-Search
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi), SMART (http://
smart.embl-heidelberg.de), and COILS (http://www.ch.embnet.org/
software/COILS_form.html). The neighbor-joining tree was drawn
using GENETYX software (GENETYX, Tokyo, Japan).
Retrovirus infection and FTOC. The retrovirus vector pMRX-
IRES-EGFP [37] was used for the overexpression of cDNA in BW5147
cells or 23–1–8 cells. For the overexpression in fetal thymocytes,
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expressing shRNA, oligonucleotides encoding stem-loop shRNA
sequences (Table S2) were inserted into the BamHI-EcoRI site of
pSIREN-RetroQ, which was purchased from BD Clontech, Mountain
View, California, United States. For the expression of shRNA in fetal
thymocytes, a DNA fragment encoding IRES-EGFP was obtained from
pMRX-IRES-EGFP and inserted into the XhoI site of pSIREN-RetroQ
to monitor the shRNA-expressing cells. Further construction details
are available upon request.
Plat-E cells were transfected for retrovirus production [39].
BW5147, NIH-3T3, or 23–1–8 cells were infected with retroviruses
in the presence of 10 lg/ml polybrene. Retrovirus infection of day
14.5 B6 fetal thymocytes was previously described [40]. DN4
thymocytes were puriﬁed from day 16.5 fetal thymocytes by depleting
CD4, CD8, CD44, and CD25 using biotinylated antibodies and
streptavidin-conjugated magnetic beads (Miltenyi Biotech, Bergisch
Gladbach, Germany) (.97% purity). Retrovirus-infected fetal thy-
mocytes were transferred into 2-deoxyguanosine–treated day 15.5 B6
fetal thymus lobes by hanging drop culture, and the reconstituted
thymus lobes were cultured in conventional FTOC conditions [40].
Flow cytometry analysis and cell sorting. Multicolor ﬂow cytometry
analysis and cell sorting were performed using FACS-Calibur or
FACS-Vantage (BD Biosciences, San Jose, California, United States) as
described [40,41]. Cells with .95% purity were used. For the
detection of apoptosis in developing thymocytes, cells were stained
with phycoerythrin-conjugated Annexin V (MBL, Nagoya, Japan)
before staining for CD4 and CD8. Mitochondrial membrane potential
was analyzed by staining cells with 3,39-dihexyloxacarbocynine iodide
and propidium iodide (PI).
Quantitative RT-PCR. Real-time RT-PCR was performed with the
iQ SYBR Green Supermix and iCycler iQ Real Time PCR System (Bio-
Rad, Hercules, California, United States). Ampliﬁed signals were
conﬁrmed to be single bands over gel electrophoresis, and normal-
ized to GAPDH levels. Primer sequences are available upon request.
Antibody production. Rabbits were immunized with synthetic
peptides of mouse IAN4 (METLQNVVTGGKKGGC) and IAN5
(LQKSTYGTIVQGPEAHC) conjugated to KLH (MBL).
Antibody array and IP analysis. Antibody array analysis was
performed using Signal Transduction Array (Hypromatrix, Worces-
ter, Massachusetts, United States) according to the manufacturer’s
instructions. For IP of FLAG-tagged proteins, cell lysates in 10 mM
HEPES (pH 7.5), 150 mM NaCl, 1% CHAPS, and protease inhibitors
were incubated with agarose-bead-conjugated anti-FLAG M2 anti-
body (Sigma, St. Louis, Missouri, United States). For IP with anti-Bcl-2
(BD Biosciences) or anti-Bcl-xL (MBL) antibodies, cell lysates were
incubated with primary antibodies and agarose-bead-conjugated
protein A or G. The beads were then washed and boiled in Laemmli
gel-loading buffer before performing SDS-PAGE and IB. For IP with
anti–Bcl-2 antibody, the cell lysis buffer contained 1% Triton X-100
instead of 1% CHAPS. Subcellular fractionation was performed as
described [15].
Supporting Information
Figure S1. WIAN8 Is a Pseudogene
(A) Genomic localization of mouse IAN family genes spanning
between previously predicted IAN8 and IAN4 is shown [17]. cDNAs
prepared from thymocytes (Thy) and splenocytes (Spl) of C57BL/6
mice were PCR-ampliﬁed for indicated genes. Unlike the expression
of the other IAN family genes, the expression of putative IAN8 was
not detected in thymocytes or splenocytes. A portion of this putative
gene (360 bp) was also PCR-ampliﬁed from C57BL/6 genomic DNA
(Gen) and sequenced.
(B) Nucleotide sequence and deduced three frames of amino acid
sequences show multiple frame shifts, including a stop codon (nt 270–
272, boxed) within possible coding frames (underlined). Provisional
GTP-binding motifs (G1, G2, and G3) are boxed. Thus, this gene
previously predicted as IAN8 is a pseudogene. We renamed this locus
WIAN8.
Found at DOI: 10.1371/journal.pbio.0040103.sg001 (446 KB PDF).
Figure S2. Mouse IAN9 Gene
(A) Diagram of the genomic region between the hypothetical protein
C130032F08geneandWIAN8.Apreviousreportpredictedthreegenes
(IAN9, IAN10, and IAN11) in this region [17], and we indeed found
three putative ORFs encoding GTP-binding IAN proteins (GTP-
binding motifs; open boxes). However, a computer search for these
putative ORFs in the NCBI public database revealed a hypothetical
transcript (accession number XM_144696) that covers the sequence
ranging from the 59-end of IAN11 to the 39-end of IAN9 and encodes a
protein with three GTP-binding motifs. Filled boxes represent its
exons, with putative positions of start (ATG) and stop codons.
(B) To examine whether IAN9, IAN10, and IAN11 comprise three
independent genes or a single gene, we performed RT-PCR analysis
with primers matching the 59-end of IAN11 and the 39-end of IAN9.A
2.2-kb PCR product was detected from thymocytes (Thy) and
splenocytes (Spl), and its nucleotide sequence was identical to that
of the hypothetical transcript.
(C and D) Either probe 1 that matches IAN11 or probe 2 that matches
IAN9 hybridized to a transcript of approximately 3 kb without any
other transcripts in the Northern blot analysis. Thus, this genomic
region in which the three IAN genes were previously predicted
transcribes a single mRNA that encodes a putative 688 aa protein
with three GTP-binding motifs. We renamed this gene IAN9
(accession number AB178029).
Found at DOI: 10.1371/journal.pbio.0040103.sg002 (240 KB PDF).
Figure S3. Structural Similarity between IAN4 and IAN5
(A) Similarity in amino acid sequences among mouse IAN family
proteins is summarized. Amino acid sequence homology was
calculated with GENETYX software. IAN4 and IAN5 showed the
highest similarity (as enclosed in a box).
(B) Sequence alignment of mouse IAN4 and IAN5.
Asterisks represent identical amino acids.
GTP-binding motifs (G1, G2, G3, and G4), IAN motifs, coiled-coil
motifs, and hydrophobic regions are boxed.
(C) Membrane blots containing 3 lg per lane of poly(A)
þ RNA from
the thymus and spleen of C57BL/6 mice were hybridized with
32P-
labeled IAN4-ORF, IAN4-speciﬁc, IAN5-speciﬁc, or GAPDH probe.
Total RNA was electrophoresed in the same gel, and the positions of
28S and 18S ribosomal RNAs are indicated.
Arrows indicate position and predicted size of the transcripts.
The two bands observed with the IAN4-ORF probe correspond to
IAN4 and IAN5 transcripts.
Found at DOI: 10.1371/journal.pbio.0040103.sg003 (54 KB PDF).
Figure S4. Speciﬁc Knockdown of IAN1, IAN4, and IAN5 in
Thymocyte Development
Day 14.5 fetal thymocytes infected with shRNA retroviruses were
reconstituted in FTOC. EGFP
þ cells puriﬁed on day 6 were analyzed
for mRNA expression. Relative mRNA levels normalized to GAPDH
levels are shown.
Found at DOI: 10.1371/journal.pbio.0040103.sg004 (171 KB PDF).
Figure S5. Antibody Array Analysis
293T cells transfected with HA-tagged IAN4 were lysed with buffer
containing 0.5% Triton X-100. An antibody array membrane was
incubated with the lysate and blotted with peroxidase-conjugated
anti-HA antibody. An area of the array containing Bcl-2 family
members is magniﬁed in the box.
Found at DOI: 10.1371/journal.pbio.0040103.sg005 (310 KB PDF).
Figure S6. Subcellular Localization of IAN1, IAN4, and IAN5
(A) BW5147 cells expressing EGFP alone, EGFP-IAN1, EGFP-IAN4, or
EGFP-IAN5 were stained with BODIPY-labeled BFA, MitoRed, or
anti-CD44-PE.
(B) BW5147 cells expressing IAN1-HA, IAN4, IAN5, or EGFP were
subjected to subcellular fractionation. Whole lysate (WL), nuclear (N),
heavy membrane (HM) and cytoplasmic (C) fractions were analyzed
by IB for IAN1-HA, IAN4, IAN5, EGFP, poly ADP-ribose polymerase
(PARP), calnexin, cytochrome c oxidase 4 (COX4), Crk, or Bcl-2.
PARP, calnexin, COX4, and Crk were enriched in the nuclei,
endoplasmic reticulum, mitochondria, and cytoplasmic fractions,
respectively, and used as markers for the fractionation.
Found at DOI: 10.1371/journal.pbio.0040103.sg006 (209 KB PDF).
Table S1. Oligonucleotide Microarray Analysis of H-2
b AND-TCR–
Transgenic Thymocytes and C57BL/6 Thymocytes
The fold difference of representative genes in two independent
experiments is shown. Note that the expression of IAN1 and IAN4 is
higher in AND-TCR–transgenic thymocytes than in C57BL/6 thymo-
cytes. It was shown that CCR7 is more highly expressed in mature SP
thymocytes than in immature thymocytes [46], whereas RAG1 and
RAG2 are more highly expressed in immature thymocytes than in
mature thymocytes [47].
CCR7, CC chemokine receptor 7; GAPDH, glyceraldehyde 3-phos-
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IAN Family in T Lymphocyte Developmentphate dehydrogenase; RAG1 and RAG2, recombination activating
genes 1 and 2; Rps5, ribosomal protein S5; Tuba1, tubulin alpha 1.
Found at DOI: 10.1371/journal.pbio.0040103.st001 (14 KB PDF).
Table S2. Oligonucleotide Sequence and Predicted Secondary
Structure of shRNA
Double-stranded oligonucleotides encoding the sequences of the
sense (19 nucleotides, underlined), the loop (TTCAAGAGA, bold), the
antisense (19 nucleotides, underlined), and the terminator (TTTTTT)
were synthesized to design shRNA, and were cloned downstream of a
PolIII-dependent U6 promoter in the pSIREN-RetroQ vector (BD
Clontech). The sequences of the synthesized oligonucleotides and the
predicted secondary structure of the shRNA are listed.
Found at DOI: 10.1371/journal.pbio.0040103.st002 (18 KB PDF).
Accession Numbers
The Genbank (http://www.ncbi.nih.gov/Genbank) accession numbers
for the genes and gene products discussed in this paper are: mouse
IAN1/gimap4 (NM_174990.3), mouse IAN2/gimap1 (NM_008376.3),
mouse IAN3/gimap7 (NM_146167.3), mouse IAN4/gimap3
(AB164418.1), mouse IAN5/gimap5 (AB126961.1), mouse IAN6/gimap6
(NM_153175.3), mouse IAN7/gimap9 (BC096680.1), mouse IAN9/
gimap8 (AB178029), rat IAN1/gimap4 (NM_173153), human IAN1/
gimap4 (NM_018326), mouse GAPDH (M32599.1), mouse bcl-2
(L31532.1), human bcl-xL (Z23115.1), human bax (NM_138761.2),
human bak (NM_001188.2), human bad (NM_004322.2), human
bimEL (AF032457.1), and human IjBa(AY033600.1).
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